Cerenis Therapeutics

cerenis.com

Cerenis Therapeutics is a multinational biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases. Therapies focused on increasing HDL (good cholesterol) represent the next frontier in the treatment of cardiovascular disease. Clinical evidence has demonstrated that HDL therapy can rapidly regress atherosclerotic plaque and elevating HDL can reduce cardiovascular morbidity and mortality. Cerenis is developing what has the potential to be the first-to-market and best-in-class recombinant HDL (CER-001). CER-001 has successfully completed Phase I. The product is designed to rapidly regress atherosclerotic plaque among patients at high risk of cardiovascular events. It is based on Cerenis’ multiple breakthroughs in the science of HDL, which have allowed the identification and development of highly potent and pure HDL particles.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Chemical Management

ALLIED COPPER REPORTS ADDITIONAL FINANCIAL AND TECHNICAL INFORMATION FOR VOLT LITHIUM CORP.

Allied Copper Corporation | November 25, 2022

news image

Allied Copper Corp. is pleased to announce additional technical information and financial information regarding Volt Lithium Corp. As announced on October 31, 2022, Allied Copper has agreed to acquire 100% of the issued and outstanding shares of privately-held Volt, pursuant to a share purchase agreement dated October 31, 2022, among each of the shareholders of Volt. Through this Acquisition, Allied Copper is afforded a strategic opportunity to expand both its asset base and development focus to...

Read More

Chemical Management

CARBON CAPTURE & REMOVAL SOLUTIONS PROVIDER, SVANTE, RESPONDS TO THE US’S NEW INFLATION REDUCTION ACT

Svante | August 18, 2022

news image

The following is an official statement about the US’s enactment of the Inflation Reduction Act, made by Claude Letourneau, President and CEO of leading Canadian carbon capture and removal solutions provider, Svante. The US’s Inflation Reduction Act, signed into law on Tuesday by President Biden, is a monumental bill that truly demonstrates America’s commitment to climate action and a way to monetize CO2 emissions to develop a viable carbon management industry. Read More

Chemical Management

CAVITATION TECHNOLOGIES INC. EXPANDS INTERNATIONAL OPERATIONS AS ALFA LAVAL ACQUIRES ITS STRATEGIC PARTNER DESMET BALLESTRA

Cavitation Technologies Inc. | April 06, 2022

news image

Cavitation Technologies, Inc. announces its plans to expand international operations as one of its key strategic partners Desmet Ballestra a world leader in edible oil and biofuel processing, was acquired by Alfa Laval (listed in Stockholm STO: ALFA and in USA OTC: ALFVY) a leading global provider of first-rate products in the areas of heat transfer, separation, and fluid handling. By signing the Agreement announced on March 31, 2022, Alfa Laval and Desmet Ballestra are no longer ...

Read More

EXECUTIVES FROM U.S., CANADIAN, AND MEXICAN CHEMICAL INDUSTRIES REAFFIRM SUPPORT FOR NEW NORTH AMERICAN TRADE AGREEMENT

Benzinga | January 16, 2020

news image

Leading executives representing the U.S., Canadian and Mexican chemical industries today publicly reaffirmed their support for U.S. ratification of the United States-Mexico-Canada Agreement (USMCA), also known as the Canada-United States-Mexico Agreement (CUSMA) in Canada and the Tratado entre México, Estados Unidos y Canadá (T-MEC) in Mexico. The announcement, led by American Chemistry Council (ACC) President and CEO, Chris Jahn; Chemistry Industry Association of Canada (CIAC) Pre...

Read More
news image

Chemical Management

ALLIED COPPER REPORTS ADDITIONAL FINANCIAL AND TECHNICAL INFORMATION FOR VOLT LITHIUM CORP.

Allied Copper Corporation | November 25, 2022

Allied Copper Corp. is pleased to announce additional technical information and financial information regarding Volt Lithium Corp. As announced on October 31, 2022, Allied Copper has agreed to acquire 100% of the issued and outstanding shares of privately-held Volt, pursuant to a share purchase agreement dated October 31, 2022, among each of the shareholders of Volt. Through this Acquisition, Allied Copper is afforded a strategic opportunity to expand both its asset base and development focus to...

Read More
news image

Chemical Management

CARBON CAPTURE & REMOVAL SOLUTIONS PROVIDER, SVANTE, RESPONDS TO THE US’S NEW INFLATION REDUCTION ACT

Svante | August 18, 2022

The following is an official statement about the US’s enactment of the Inflation Reduction Act, made by Claude Letourneau, President and CEO of leading Canadian carbon capture and removal solutions provider, Svante. The US’s Inflation Reduction Act, signed into law on Tuesday by President Biden, is a monumental bill that truly demonstrates America’s commitment to climate action and a way to monetize CO2 emissions to develop a viable carbon management industry. Read More

news image

Chemical Management

CAVITATION TECHNOLOGIES INC. EXPANDS INTERNATIONAL OPERATIONS AS ALFA LAVAL ACQUIRES ITS STRATEGIC PARTNER DESMET BALLESTRA

Cavitation Technologies Inc. | April 06, 2022

Cavitation Technologies, Inc. announces its plans to expand international operations as one of its key strategic partners Desmet Ballestra a world leader in edible oil and biofuel processing, was acquired by Alfa Laval (listed in Stockholm STO: ALFA and in USA OTC: ALFVY) a leading global provider of first-rate products in the areas of heat transfer, separation, and fluid handling. By signing the Agreement announced on March 31, 2022, Alfa Laval and Desmet Ballestra are no longer ...

Read More
news image

EXECUTIVES FROM U.S., CANADIAN, AND MEXICAN CHEMICAL INDUSTRIES REAFFIRM SUPPORT FOR NEW NORTH AMERICAN TRADE AGREEMENT

Benzinga | January 16, 2020

Leading executives representing the U.S., Canadian and Mexican chemical industries today publicly reaffirmed their support for U.S. ratification of the United States-Mexico-Canada Agreement (USMCA), also known as the Canada-United States-Mexico Agreement (CUSMA) in Canada and the Tratado entre México, Estados Unidos y Canadá (T-MEC) in Mexico. The announcement, led by American Chemistry Council (ACC) President and CEO, Chris Jahn; Chemistry Industry Association of Canada (CIAC) Pre...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us